Phase IV Clinical Study of Immunogenicity of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector)
Phase IV Clinical Study of Immunogenicity of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector)
Active, not recruiting · NCT05935176 · Registry updated 2026-03-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase IV Clinical Study of Immunogenicity of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector) | Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, Infections, Neisseriaceae Infections, Neuroinflammatory Diseases, bacterial infectious disease, bacterial meningitis, central nervous system disorder, central nervous system infectious disorder, gram-negative bacterial infections, meningitis, meningococcal infection, meningococcal meningitis, nervous system disorder | Active, not recruiting | Phase 4 | 2026-03-04 | NCT05935176 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| CanSino Biologics Inc. | 14 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Wuzhi County Center for Disease Control and Prevention | Jiaozuo | China | 1 |